IBO (Impact BioMedical, Inc.) Stock Analysis - SEC Filings

Impact BioMedical, Inc. (IBO) is a publicly traded Healthcare sector company. As of May 21, 2026, IBO trades at $0.53 with a market cap of $58.04M and a P/E ratio of -1.52. IBO moved +4.03% today. Year to date, IBO is +3.30%; over the trailing twelve months it is -3.03%. Its 52-week range spans $0.36 to $6.17. Rallies surfaces IBO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find IBO SEC filings?

Rallies organizes IBO SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

IBO Key Metrics

Key financial metrics for IBO
MetricValue
Price$0.53
Market Cap$58.04M
P/E Ratio-1.52
EPS$-0.38
Dividend Yield0.00%
52-Week High$6.17
52-Week Low$0.36
Volume839
Avg Volume0
Revenue (TTM)$0
Net Income$-11.87M
Gross Margin0.00%

Latest IBO News

Recent IBO Insider Trades

  • Macko Todd D sold 43.40K (~$24.37K) on Mar 27, 2026.
  • Macko Todd D sold 1.60K (~$961.28) on Mar 25, 2026.
  • Grady Jason sold 50.00K (~$32.51K) on Mar 23, 2026.

IBO Analyst Consensus

IBO analyst coverage data. Average price target: $0.00.

Common questions about IBO

Where can I find IBO SEC filings?
Rallies organizes IBO SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show IBO 10-K and 10-Q filings?
Rallies organizes IBO SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is IBO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for IBO. It does not provide personalized investment advice.
IBO

IBO